Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Research article

Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians

Authors: Matthew T Haren, Ming Li, John Petkov, Robyn A McDermott

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

The interaction between overweight/obesity and alcohol intake on liver enzyme concentrations have been demonstrated. No studies have yet examined the interaction between metabolic syndrome or multiple metabolic risk factors and alcohol intake on liver enzymes. The aim of this study was to examine if alcohol consumption modifies the effect of metabolic risk on elevated serum GGT in Indigenous Australians.

Methods

Data were from N = 2609 Indigenous Australians who participated in a health screening program in rural far north Queensland in 1999-2000 (44.5% response rate). The individual and interactive effects of metabolic risk and alcohol drinking on elevated serum GGT concentrations (≥50 U/L) were analyzed using logistic regression.

Results

Overall, 26% of the population had GGT≥50 U/L. Elevated GGT was associated with alcohol drinking (moderate drinking: OR 2.3 [95%CI 1.6 - 3.2]; risky drinking: OR 6.0 [4.4 - 8.2]), and with abdominal obesity (OR 3.7 [2.5 - 5.6]), adverse metabolic risk cluster profile (OR 3.4 [2.6 - 4.3]) and metabolic syndrome (OR 2.7 [2.1 - 3.5]) after adjustment for age, sex, ethnicity, smoking, physical activity and BMI. The associations of obesity and metabolic syndrome with elevated GGT were similar across alcohol drinking strata, but the association of an adverse metabolic risk cluster profile with elevated GGT was larger in risky drinkers (OR 4.9 [3.7 - 6.7]) than in moderate drinkers (OR 2.8 [1.6 - 4.9]) and abstainers (OR 1.6 [0.9 - 2.8]).

Conclusions

In this Indigenous population, an adverse metabolic profile conferred three times the risk of elevated GGT in risky drinkers compared with abstainers, independent of sex and ethnicity. Community interventions need to target both determinants of the population's metabolic status and alcohol consumption to reduce the risk of elevated GGT.
Appendix
Available only for authorised users
Literature
1.
Moreno-Sanchez D: [Epidemiology and natural history of primary nonalcoholic fatty liver disease]. Gastroenterol Hepatol. 2006, 29 (4): 244-254. 10.1157/13085972.CrossRefPubMed
2.
Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, Olgac V, Sonsuz A, Ozbay G, et al: Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology. 2008, 55 (85): 1433-1438.PubMed
3.
Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA: Alanine aminotransferase, gamma glutamyltransferase and incident diabetes: The British Women's Heart and Health Study and meta-analysis. Diabetes Care. 2009, 32 (4): 741-51. 10.2337/dc08-1870.CrossRefPubMedPubMedCentral
4.
Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA: Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2007, 27 (12): 2729-2735. 10.1161/ATVBAHA.107.152298.CrossRefPubMed
5.
Leonard D, McDermott R, Odea K, Rowley KG, Pensio P, Sambo E, Twist A, Toolis R, Lowson S, Best JD: Obesity, diabetes and associated cardiovascular risk factors among Torres Strait Islander people. Aust N Z J Public Health. 2002, 26 (2): 144-149. 10.1111/j.1467-842X.2002.tb00907.x.CrossRefPubMed
6.
Daniel M, Rowley KG, McDermott R, O'Dea K: Diabetes and impaired glucose tolerance in Aboriginal Australians: prevalence and risk. Diabetes Res Clin Pract. 2002, 57 (1): 23-33. 10.1016/S0168-8227(02)00006-2.CrossRefPubMed
7.
Schutte AE, Shemesh T, Rowley K, Best JD, McDermott R, O'Dea K: The metabolic syndrome and changing relationship between blood pressure and insulin with age, as observed in Aboriginal and Torres Strait Islander peoples. Diabet Med. 2005, 22 (11): 1589-1597. 10.1111/j.1464-5491.2005.01747.x.CrossRefPubMed
8.
Daniel M, Rowley KG, McDermott R, Mylvaganam A, O'Dea K: Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study. Diabetes Care. 1999, 22 (12): 1993-1998. 10.2337/diacare.22.12.1993.CrossRefPubMed
9.
McDermott RA, McCulloch BG, Campbell SK, Young DM: Diabetes in the Torres Strait Islands of Australia: better clinical systems but significant increase in weight and other risk conditions among adults, 1999-2005. Med J Aust. 2007, 186 (10): 505-508.PubMed
10.
Vos T, Barker B, Begg S, Stanley L, Lopez AD: Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol. 2009, 38 (2): 470-7. 10.1093/ije/dyn240.CrossRefPubMed
11.
Alatalo P, Koivisto H, Puukka K, Hietala J, Anttila P, Bloigu R, Niemela O: Biomarkers of Liver Status in Heavy Drinkers, Moderate Drinkers and Abstainers. Alcohol Alcohol. 2009, 44 (2): 199-203.CrossRefPubMed
12.
Suter PM: Is alcohol consumption a risk factor for weight gain and obesity?. Crit Rev Clin Lab Sci. 2005, 42 (3): 197-227. 10.1080/10408360590913542.CrossRefPubMed
13.
Li M, Campbell S, McDermott R: gamma-Glutamyltransferase, Obesity, Physical Activity, and the Metabolic Syndrome in Indigenous Australian Adults. Obesity (Silver Spring). 2009, 17 (4): 809-13. 10.1038/oby.2008.617.CrossRef
14.
Alatalo PI, Koivisto HM, Hietala JP, Puukka KS, Bloigu R, Niemela OJ: Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr. 2008, 88 (4): 1097-1103.PubMed
15.
Puukka K, Hietala J, Koivisto H, Anttila P, Bloigu R, Niemela O: Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity. Am J Clin Nutr. 2006, 83 (6): 1351-1354. quiz 1448-1359PubMed
16.
Wang Z, Hoy WE: Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?. Med J Aust. 2005, 182 (2): 66-69.PubMed
17.
Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM: Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study. Bmj. 2002, 325 (7375): 1271-10.1136/bmj.325.7375.1271.CrossRefPubMedPubMedCentral
18.
Empana JP, Ducimetiere P, Arveiler D, Ferrieres J, Evans A, Ruidavets JB, Haas B, Yarnell J, Bingham A, Amouyel P, et al: Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J. 2003, 24 (21): 1903-1911. 10.1016/j.ehj.2003.09.002.CrossRefPubMed
19.
D'Agostino RB, Grundy S, Sullivan LM, Wilson P: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. Jama. 2001, 286 (2): 180-187. 10.1001/jama.286.2.180.CrossRefPubMed
20.
O'Dea K, Rowley KG: Macrovascular disease risk factors and insulin resistance in Aboriginal and Torres Strait Islander people. J Diabetes Complications. 2002, 16 (1): 9-16. 10.1016/S1056-8727(01)00195-7.CrossRefPubMed
21.
McDermott RA, Tulip F, Schmidt B: Diabetes care in remote northern Australian Indigenous communities. Med J Aust. 2004, 180 (10): 512-516.PubMed
22.
Miller G, McDermott R, McCulloch B, Leonard D, Arabena K, Muller R: The Well Person's Health Check: a population screening program in indigenous communities in north Queensland. Aust Health Rev. 2002, 25 (6): 136-147. 10.1071/AH020136b.CrossRefPubMed
23.
Australian Bureau of Statistics: 2001 Census Dictionary. 2001, Canberra: Australian Bureau of Statistics
24.
Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A: Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007, 39 (8): 1423-1434. 10.1249/mss.0b013e3180616b27.CrossRefPubMed
25.
National Health and Medical Research Council: Australian Alcohol Guidelines: Health Risks and Benefits. 2001, Canberra: National Health and Medical Research Council
26.
Alberti KG, Zimmet P, Shaw J: The metabolic syndrome--a new worldwide definition. Lancet. 2005, 366 (9491): 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed
27.
World Health Organisation: Obesity: preventing and managing the global epidemic: report of a WHO consultation on obesity, Geneva, 3-5 June, 1997. 1998, Geneva: World Health Organisation
28.
Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15 (7): 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed
29.
Nilssen O, Averina M, Brenn T, Brox J, Kalinin A, Archipovski V: Alcohol consumption and its relation to risk factors for cardiovascular disease in the north-west of Russia: the Arkhangelsk study. Int J Epidemiol. 2005, 34 (4): 781-788. 10.1093/ije/dyi078.CrossRefPubMed
30.
Wilfred de Alwis NM, Day CP: Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis. 2007, 27 (1): 44-54. 10.1055/s-2006-960170.CrossRefPubMed
31.
Wilfred de Alwis NM, Day CP: Genes and nonalcoholic fatty liver disease. Curr Diab Rep. 2008, 8 (2): 156-163. 10.1007/s11892-008-0027-9.CrossRefPubMed
32.
Lin CF, Shiau TJ, Ko YC, Chen PH, Wang JD: Prevalence and determinants of biochemical dysfunction of the liver in Atayal Aboriginal community of Taiwan: is betel nut chewing a risk factor?. BMC Gastroenterol. 2008, 8: 13-10.1186/1471-230X-8-13.CrossRefPubMedPubMedCentral
33.
34.
Lee DH, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, Tuomilehto J: Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J. 2006, 27 (18): 2170-2176. 10.1093/eurheartj/ehl086.CrossRefPubMed
35.
Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G: Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care. 2007, 30 (8): 2119-2121. 10.2337/dc07-0349.CrossRefPubMed
36.
Trewin D, Madden R: The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples 2005. 2005, Canberra: Australian Institute of Health and Welfare and Australian Bureau of Statistics
37.
Stranges S, Freudenheim JL, Muti P, Farinaro E, Russell M, Nochajski TH, Trevisan M: Differential effects of alcohol drinking pattern on liver enzymes in men and women. Alcohol Clin Exp Res. 2004, 28 (6): 949-956. 10.1097/01.ALC.0000128229.23396.42.CrossRefPubMed
38.
Stranges S, Freudenheim JL, Muti P, Farinaro E, Russell M, Nochajski TH, Trevisan M: Greater hepatic vulnerability after alcohol intake in African Americans compared with Caucasians: a population-based study. J Natl Med Assoc. 2004, 96 (9): 1185-1192.PubMedPubMedCentral
39.
Stewart SH, Connors GJ: Ethnicity, alcohol drinking and changes in transaminase activity among heavy drinkers. J Natl Med Assoc. 2007, 99 (5): 564-569.PubMedPubMedCentral
40.
Stewart SH: Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gamma-glutamyltransferase elevation. Arch Intern Med. 2002, 162 (19): 2236-2239. 10.1001/archinte.162.19.2236.CrossRefPubMed
41.
Puukka K, Hietala J, Koivisto H, Anttila P, Bloigu R, Niemela O: Age-related changes on serum ggt activity and the assessment of ethanol intake. Alcohol Alcohol. 2006, 41 (5): 522-527.CrossRefPubMed
42.
Greenfield TK, Kerr WC: Alcohol measurement methodology in epidemiology: recent advances and opportunities. Addiction. 2008, 103 (7): 1082-1099. 10.1111/j.1360-0443.2008.02197.x.CrossRefPubMedPubMedCentral
Metadata
Title
Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians
Authors
Matthew T Haren
Ming Li
John Petkov
Robyn A McDermott
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-454

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue

Research article

Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study

Research article

Household smoking and dental caries in schoolchildren: the Ryukyus Child Health Study

Research article

Assessing weight perception accuracy to promote weight loss among U.S. female adolescents: A secondary analysis

Research article

Rapid Health and Needs assessments after disasters: a systematic review

Research article

Cardiovascular risk estimated after 13 years of follow-up in a low-incidence Mediterranean region with high-prevalence of cardiovascular risk factors

Study protocol

TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes